Example: Heart Attack

Search clinical trials for: Prescriptive Infusion Algorithm

Total 6211 results

NCT02607956

Completed

Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

HIV-1 Infection
NCT06865911

Completed

Cold Versus Warm Tumescent Solution in Arm Liposculpture

Liposuction | Arm Pain | Safety of Intervention | Arm Aesthetics
NCT01111513

Completed

The Influence of the Femoral Nerve Block on Quadriceps Strength

Total Knee Arthroplasty
NCT06774274

Recruiting

Analgesic Efficacy of Intravenous Ketamine as a Continuous Infusion vs PCA in the Management of Acute Postoperative Pain in Major Orthopedic Surgery.

Pain, Postoperative | Opioid Use | Major Surgery
NCT06747351

Recruiting

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT06554600

Recruiting

A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma

Refractory or Relapsed Diffuse Large B Cell Lymphoma
NCT02498912

Active, not recruiting

Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors

Solid Tumors
NCT01566890

Completed

Microvascular Blood Flow in Sickle Cell Anemia

Sickle Cell Disease | Sickle Cell Anemia
NCT00803309

Terminated

Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients (OPTEX2/3)

Hepatitis C, Chronic
NCT02648438

Completed

A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male Subjects

Asthma | Chronic Obstructive Pulmonary Disease (COPD)
NCT01464008

Completed

The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C

Chronic Hepatitis C
NCT02183610

Completed

Investigation of the Metabolism and Pharmacokinetics of 10 mg [14C] BI 1356 Administered Orally Compared to 5 mg [14C] BI 1356 Administered Intravenously in Healthy Male Volunteers

Healthy
NCT00948753

Completed

Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation

Hematopoietic Stem Cell Transplantation | Graft-versus-host Disease
NCT07493538

Recruiting

MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases

Acute Myeloid Leukemia | Myelodysplastic Syndromes | AML | Acute Leukemia | MDS
NCT07263984

Recruiting

Added Value of Three-dimensional Transvaginal Ultrasound (3D TVUS) and Gel Infusion Sonography (3D GIS) Compared With Magnetic Resonance Imaging (MRI) in the Diagnosis of Patients With Suspicion of a Uterine Septum. (SEPTUM-D)

Uterine Septum
NCT04603872

Recruiting

CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

Acute Lymphoblastic Leukemia, in Relapse | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Acute Lymphocytic Leukaemia Refractory
NCT06199297

Completed

Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma
NCT01952574

Completed

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention

Migraine
NCT01852071

Completed

Autologous CD34+ Hematopoietic Stem Cells Transduced ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for the Human ADA Gene

ADA-SCID
NCT01380990

Completed

Lentiviral (LV) Gene Therapy for Adenosine Deaminase (ADA) Deficiency

Adenosine Deaminase Deficiency | Severe Combined Immunodeficiencies (SCID)
NCT00982072

Completed

Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease (MinTAC)

Minimal Change Disease
NCT01821963

Terminated

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Infection
NCT02916927

Completed

Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department

Pain
NCT03638401

Completed

Epidural vs. Wound Catheter Following Liver Resection

Transplant Surgery
NCT01100255

Completed

Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder
NCT02393599

Completed

Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin

Cocaine Abuse
NCT00877812

Completed

Vitamin B6 Dependence of One-Carbon Metabolism

Vitamin B6 Deficiency
NCT00401492

Completed

MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer

Non Small Cell Lung Cancer
NCT00093093

Completed

Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive (VISER2)

Chronic Hepatitis C
NCT00575627

Unknown

Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels

Chronic Hepatitis C
NCT06498973

Recruiting

Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

Acute Myeloid Leukemia | Myelodysplastic Syndrome
NCT05862064

Recruiting

A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer

TNBC - Triple-Negative Breast Cancer
NCT02814279

Completed

Comparison of Two Flaps for Root Coverage

Gingival Recession
NCT05106751

Completed

A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial Folds

Correction of Nasolabial Folds
NCT00602576

Completed

Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma

Melanoma (Skin)
NCT00933023

Withdrawn

Mild Versus Potent Corticosteroids as Treatment for Phimosis in Children (TopSteP)

Phimosis
NCT02000596

Terminated

1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.

Metastatic Breast Cancer
NCT00294398

Completed

Inhaled Corticosteroids After a Pediatric Emergency Visit for Asthma

Asthma
NCT01157026

Completed

A Pilot Clinical Trial With Tocotrienol on Breast Cancer (BC)

Breast Cancer
NCT01142921

Terminated

The Patency Period of the New Plastic Anti-reflux Biliary Stent

Pancreatitis | Cholangitis
NCT00169221

Terminated

Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas

Head and Neck Cancer
NCT07608081

Recruiting

The Value of Time-Dependent Diffusion MRI and Magnetic Resonance Elastography in the Precise Diagnosis and Efficacy Assessment of Breast Cancer

Breast Cancer
NCT05480111

Completed

The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy

Pain, Postoperative
NCT03482492

Completed

Tramadol vs.Tramadol With Paracetamol

Lumbar Disc Herniation
NCT01053169

Completed

Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)

Coagulation Protein Disorders | Perioperative Care | Blood Loss, Surgical
NCT06212141

Active, not recruiting

Comparison of Bulk-Fill Composite Resins in Class II Restorations

Class II Dental Caries
NCT04433546

Terminated

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). (VANGARD)

Pneumonia | Respiratory Failure | Respiratory Insufficiency | COVID 19 | Acute Respiratory Distress Syndrome | SARS-CoV-2 | Coronavirus | Cytokine Storm | Pulmonary Edema | Cardiac Event
NCT06878664

Recruiting

Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors (RIALTO)

Grade1-2 Advanced Midgut Neuroendocrine Tumors (NETs)
NCT00313508

Completed

Dendritic Cell Vaccination During Lymphoid Reconstruction

Intraocular Melanoma | Melanoma (Skin)
NCT02059889

Withdrawn

Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer

Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung Cancer

Search clinical trials for: Prescriptive Infusion Algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations